1. Johnston LD, O’Malley PM, Miech RA, Bachman JG, Schulenberg JE (2014) Monitoring the future national survey results on drug use, 1975–2014: overview, key findings on adolescent drug use.
http://www.monitoringthefuture.org/pubs/monographs/mtf-overview2014.pdf
. Accessed 12 June 2017
2. Johnston LD, O’Malley PM, Miech RA, Bachman JG, Schulenberg JE (2017) Monitoring the future national survey results on drug use, 1975–2016: overview, key findings on adolescent drug use. Institute for Social Research, The University of Michigan, Ann Arbor.
http://monitoringthefuture.org/pubs/monographs/mtf-overview2016.pdf
. Accessed 2017
3. Hill KP (2015) Medical marijuana for treatment of chronic pain and other medical and psychiatric problems: a clinical review. JAMA 313(24):2474–2483
4. Koppel BS, Brust JC, Fife T, Bronstein J, Youssof S, Gronseth G et al (2014) Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the guideline development subcommittee of the American Academy of Neurology. Neurology 82(17):1556–1563
5. Flachenecker P, Henze T, Zettl UK (2014) Nabiximols (THC/CBD oromucosal spray, Sativex(R)) in clinical practice—results of a multicenter, non-interventional study (MOVE 2) in patients with multiple sclerosis spasticity. Eur Neurol 71(5–6):271–279